BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $46,835,565 | +448.7% | 1,154,723 | +589.5% | 0.23% | +385.4% |
| Q4 2022 | $8,536,303 | -51.5% | 167,477 | -23.5% | 0.05% | -57.5% |
| Q3 2021 | $17,613,000 | +18.4% | 218,984 | +18.5% | 0.11% | +9.7% |
| Q2 2021 | $14,871,000 | -72.9% | 184,737 | -71.6% | 0.10% | -74.3% |
| Q1 2021 | $54,925,000 | -26.4% | 651,235 | -29.9% | 0.40% | -35.9% |
| Q4 2020 | $74,576,000 | +31.7% | 929,416 | +32.0% | 0.63% | +32.9% |
| Q3 2020 | $56,617,000 | +1008.6% | 704,016 | +1086.9% | 0.47% | +712.1% |
| Q2 2020 | $5,107,000 | +252.2% | 59,315 | +257.9% | 0.06% | +132.0% |
| Q3 2019 | $1,450,000 | -51.9% | 16,575 | -55.3% | 0.02% | -72.5% |
| Q1 2019 | $3,013,000 | +458.0% | 37,056 | +351.9% | 0.09% | +279.2% |
| Q4 2018 | $540,000 | -54.7% | 8,200 | -49.2% | 0.02% | -25.0% |
| Q2 2018 | $1,192,000 | +382.6% | 16,148 | +324.9% | 0.03% | +433.3% |
| Q1 2018 | $247,000 | -73.3% | 3,800 | -78.7% | 0.01% | -73.9% |
| Q1 2017 | $926,000 | -28.2% | 17,865 | -47.1% | 0.02% | -75.0% |
| Q4 2015 | $1,289,000 | -85.2% | 33,798 | -73.5% | 0.09% | -78.2% |
| Q1 2015 | $8,735,000 | – | 127,513 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |